What is Celldex Therapeutics Inc?
, a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases. The company's drug candidates include monoclonal and bispecific antibodies designed to address mast cell mediated diseases for which available treatments are inadequate. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 2.15B.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.